10 minute education • 27-9-2015 • Dr David Fitchett

SGLT2 inhibitor outcome trials: Future opportunities

Dr Fitchett discusses the unmet glycemic control needs, the ongoing clinical trials with SGLT2 inhibitors and the EMPA-REG OUTCOME trial